Synapse - Works

Results (5225)

Trajectory patterns of circulating tumor cells (CTC) in chemotherapy-treated metastatic breast cancer (MBC) patients predict poor clinical outcomes: CALGB 40502 (Alliance)/NCCTG N063H study

Meeting Abstract

Magbanua, M. J.; Hendrix, L.; Hyslop, T.; Barry, W. T.; Winer, E. P.; Hudis, C.; Toppmeyer, D.; Burnstein, H.; Qadir, M.; Ma, C.; more...
Cancer Research (2018)

Fulltext@MSK | Save

NRG Oncology/NSABP B-51/RTOG 1304: Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to breast RT post breast-conserving surgery (BCS) reduces invasive breast cancer recurrence-free interval (IBCR-FI) in patients (pts) with positive axillary (PAx) nodes who are ypN0 after neoadjuvant chemotherapy (NC)

Meeting Abstract

Mamounas, E. P.; Bandos, H.; White, J. R.; Julian, T. B.; Khan, A. J.; Shaitelman, S. F.; Torres, M. A.; Vicini, F. A.; Ganz, P. A.; McCloskey, S. A.; more...
Cancer Research (2018)

Fulltext@MSK | Save

Molecular subtyping of male breast cancer by the International Male Breast Cancer Program (IMBC): EORTC 10085/TBCRC 0-29/BIG 2-07/NABCG/BOOG 2009-04

Meeting Abstract

Martens, J. W. M.; Sieuwerts, A.; Ponchet, C.; Smid, M.; de Weerd, V.; Slaets, L.; Piper, T.; van Deurzen, C. H. M.; Schroder, C. P.; Stangle, C.; more...
Cancer Research (2018)

Fulltext@MSK | Save

Discovery and characterization of an estrogen bound lncRNA in late-stage breast cancer

Meeting Abstract

Maher, C. A.; Silva-Fisher, J.; Eteleeb, A.; Tang, C.; Perou, C.; Reis-Filho, J. S.; Mardis, E. R.; Ellis, M. J.
Cancer Research (2018)

Fulltext@MSK | Save

Health-related quality of life during a phase 2 study of talazoparib in patients with advanced breast cancer and germline BRCA1/2 mutations (ABRAZO)

Meeting Abstract

Hurvitz, S. A.; Turner, N. C.; Telli, M. L.; Rugo, H. S.; Mailliez, A.; Ettl, J.; Grischke, E. M.; Mina, L. A.; Balmaña, J.; Fasching, P. A.; more...
Cancer Research (2018)

Fulltext@MSK | Save

Circulating tumor DNA in HER2 amplified breast cancer: A translational research substudy of the NeoALTTO phase 3 trial

Meeting Abstract

Ignatiadis, M.; Silva, M. J.; Campbell, C.; Bradbury, I.; de Azambuja, E.; Maetens, M.; Fumagalli, D.; Rodrik-Outmezguine, V.; Di Cosimo, S.; Rosa, D.; more...
Cancer Research (2018)

Fulltext@MSK | Save

Olaparib monotherapy versus chemotherapy for patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: Asian subgroup analysis from the phase III OlympiAD trial

Meeting Abstract

Im, S. A.; Xu, B.; Li, W.; Robson, M.; Ouyang, Q.; Yeh, D. C.; Iwata, H.; Park, Y. H.; Sohn, J. H.; Tseng, L. M.; more...
Cancer Research (2018)

Fulltext@MSK | Save

Phase 1 study of CB-839, a first-in-class oral inhibitor of glutaminase, in combination with paclitaxel in patients with advanced triple negative breast cancer

Meeting Abstract

Kalinsky, K.; Harding, J. J.; DeMichele, A.; Infante, J. R.; Gogineni, K.; Owonikoko, T. K.; Isakoff, S.; Iliopoulos, O.; Patel, M. R.; Munster, P.; more...
Cancer Research (2018)

Fulltext@MSK | Save

Molecular determinants of post-mastectomy breast cancer recurrence

Meeting Abstract

Keene, K. S.; King, T.; Hwang, E. S.; Peng, B.; McGuire, K.; Tapia, C.; Zhang, H.; Bae, S.; Nakhlis, F.; Klauber-Demore, N.; more...
Cancer Research (2018)

Fulltext@MSK | Save

Increasing the dose density of adjuvant chemotherapy by shortening intervals between courses or by sequential drug administration significantly reduces both disease recurrence and breast cancer mortality: An EBCTCG meta-analysis of 21,000 women in 16 randomised trials

Meeting Abstract

Gray, R.; Bradley, R.; Braybrooke, J.; Davies, C.; Pan, H.; Peto, R.; Bliss, J.; Cameron, D.; Mackey, J.; Del Mastro, L.; more...
Cancer Research (2018)

Fulltext@MSK | Save